PDE3 cyclic nucleotide phosphodiesterases and the compartmentation of cyclic nucleotide-mediated signalling in cardiac myocytes

Basic Research in Cardiology, Supplement

Volumn 97, Issue 1, 2002, Pages

  Movsesian, Matthew A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cardiomyopathy; Cyclic nucleotides; Phosphodiesterase; Protein phosphorylation; Signal transduction

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC NUCLEOTIDE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE III; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE III INHIBITOR; ENZYME; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE; UNCLASSIFIED DRUG;

BLOOD VESSEL; CELL COMPARTMENTALIZATION; CELL LEVEL; CELLULAR DISTRIBUTION; CHRONICITY; DRUG ACTIVITY; DRUG EFFECT; DRUG EXPOSURE; ENZYME INHIBITION; HEART DILATATION; HEART MUSCLE CELL; HEMODYNAMIC PARAMETERS; HUMAN; MOLECULAR BIOLOGY; MUSCLE CELL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMALS; HUMANS; ISOENZYMES; MOLECULAR BIOLOGY; MYOCYTES, CARDIAC; NUCLEOTIDES, CYCLIC; SIGNAL TRANSDUCTION;

EID: 0036278525     PISSN: 01759418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells
2. Protein kinase B/Akt induces resumption of meiosis in Xenopus oocytes
3. cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium
4. Compartments of cyclic AMP and protein kinase in mammalian cardiomyocytes
5. Human platelet cGI-PDE: Expression in yeast and localization of the catalytic domain by deletion mutagenesis
6. Identification of a novel isoform of the cyclic nucleotide phosphodiesterase PDE3A expressed in vascular smooth muscle myocytes
7. The molecular biology of cyclic nucleotide phosphodiesterases
8. Inhibition by cAMP of Ras-dependent activation of Raf
9. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration
10. Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A
11. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart
12. m cyclic AMP phosphodiesterases in cardiac cells
13. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart
14. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity
15. 1
16. Expression and characterization of deletion recombinants of two cGMP-inhibited cyclic nucleotide phosphodiesterases (PDE-3)
17. 2+ transients
18. Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double-injury model
19. 2+ channels by beta-adrenergic agonists
20. Multiple transcripts for the human cardiac form of the cGMP-inhibited cAMP phosphodiesterase
21. Cardiac type cGMP-inhibited phosphodiesterase (PDE3A) gene structure: Similarity and difference to adipocyte type PDE3B gene
22. Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 isoforms
23. Insulin-induced phosphorylation and activation of cyclic nucleotide phosphodiesterase 3B by the serine-threonine kinase akt
24. Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation
25. Stimulation of renin secretion by nitric oxide is mediated by phosphodiesterase 3
26. Regulation of mitogen-activated protein kinase cascade in adult rat heart preparations in vitro
27. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: Differential subcellular localization and regulated expression by cyclic AMP
28. Stimulation by insulin of a serine kinase in human platelets that phosphorylates and activates the cGMP-inhibited cAMP phosphodiesterase
29. Insulin induced phosphorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human platelets
30. Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium
31. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets
32. Adenoviral gene transfer of activated phosphatidylinositol 3′-kinase and akt inhibits apoptosis of hypoxic cardiomyocytes in vitro
33. Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase
34. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
35. Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: Shifting the focus from inotropy to cAMP
36. Evaluation of the effect of phosphodiesterase inhibitors on mortality in chronic heart failure patients
37. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors: Role of protein kinase A in vascular smooth muscle cell mitogenesis
38. Effects of cilostazol on angiographic restenosis after coronary stent placement
39. Mutational mapping of kinetic and pharmacological properties of a human cardiac cAMP phosphodiesterase
40. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol
41. Inotropic responses to isoproterenol and phosphodiesterase inhibitors in intact guinea pig hearts: Comparison of cyclic AMP levels and phosphorylation of sarcoplasmic reticulum and myofibrillar proteins
42. Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocyte cGMP-inhibited cAMP phosphodiesterase
43. Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases
44. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: Deactivation of PDE3B in vitro by protein phosphatase type 2A
45. Downregulation by antisense oligonucleotides establishes a role for the proline-rich tyrosine kinase PYK2 in angiotensin II-induced signalling in vascular smooth muscle
46. Phosphorylation of PDE3B by phosphatidylinositol 3-kinase associated with the insulin receptor
47. NO regulates PDGF-induced activation of PKB but not ERK in A7r5 cells: Implications for vascular growth arrest
48. Regulation and function of the cyclic nucleotide phosphodiesterase PDE3 gene family
49. Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3)
50. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
51. Phospholamban: Protein structure, mechanism of action, and role in cardiac function
52. m, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium
53. Hormone-sensitive cGMP-inhibited cAMP phosphodiesterase in rat adipocytes: Regulation of insulin- and cAMP-dependent activation by phosphorylation
54. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase
55. Expression and mutagenesis of the catalytic domain of cGMP-inhibited phosphodiesterase (PDE3) cloned from human platelets
56. Expression of constitutively active phosphatidylinositol 3 kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells
57. 2+ current in single rat ventricular cells
58. 2+ dynamics, contractility, or phospholamban phosphorylation
59. Atomic structure of PDE4: Insights into phosphodiesterase mechanism and specificity
60. Leptin inhibits insulin secretion by activation of phosphodiesterase 3B